Related News
First hepatitis E vaccine hits market in China
Source: Xinhua |
October 27, 2012, Saturday
|
Online Edition
Online Edition
THE world's first hepatitis E vaccine "Hecolin" is now available on the Chinese market, a pharmaceutical company confirmed today.
The vaccine hit the market after a two-year clinical trial involving 113,000 volunteers in east China's Jiangsu Province.
Developed by Xiamen University and Xiamen Innovax Biotech Co. Ltd. in southeast China's Fujian Province, the vaccine was approved for production in December 2011.
At a launch in the city of Xiamen, Gao Yongzhong, general manager of Xiamen Innovax, said the company is working with the government to offer the vaccine to high-risk members of the public. It is also cooperating with international organizations to introduce it to other countries.
The hepatitis E virus is shed in feces and spread through tainted water and food. The World Health Organization estimates that 20 million people around the world are infected by the virus each year.
In China, hepatitis E is now the most common type of hepatitis infecting adults. It is also widespread in South and Southeast Asia, Africa and Central America.
The vaccine hit the market after a two-year clinical trial involving 113,000 volunteers in east China's Jiangsu Province.
Developed by Xiamen University and Xiamen Innovax Biotech Co. Ltd. in southeast China's Fujian Province, the vaccine was approved for production in December 2011.
At a launch in the city of Xiamen, Gao Yongzhong, general manager of Xiamen Innovax, said the company is working with the government to offer the vaccine to high-risk members of the public. It is also cooperating with international organizations to introduce it to other countries.
The hepatitis E virus is shed in feces and spread through tainted water and food. The World Health Organization estimates that 20 million people around the world are infected by the virus each year.
In China, hepatitis E is now the most common type of hepatitis infecting adults. It is also widespread in South and Southeast Asia, Africa and Central America.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证：沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证：31120180004
- |
- 网络视听许可证：0909346
- |
- 广播电视节目制作许可证：沪字第354号
- |
- 增值电信业务经营许可证：沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
